<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Blood and Cancer</title>
<title_fa></title_fa>
<short_title>Iranian Journal of Blood and Cancer</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijbc.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-4595</journal_id_issn>
<journal_id_issn_online>2008-4609</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.61882/ijbc</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>2008-4595</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1390</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2012</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<volume>4</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Evaluating the frequency of HTLV-Ι/Π infection among blood donors, major thalassemic patients and individuals infected with hepatitis B and C viruses in Isfahan, Iran</title>
	<subject_fa>Pediatric Hematology &amp; Oncology</subject_fa>
	<subject>Pediatric Hematology &amp; Oncology</subject>
	<content_type_fa>گزارش مورد</content_type_fa>
	<content_type>Case report</content_type>
	<abstract_fa></abstract_fa>
	<abstract>Background: The human T-cell lymphotropic virus type I is the first retrovirus idenfied in humans. The virus has
been associated with adult T-cell leukemia/lymphoma, human T-lymphotropic virus type I, myelopathy/tropical
spasc paraparesis, uveis, arthris, pulmonary lymphocyc alveolis, keratoconjuncvis sicca, and infecous
dermas. Human T-lymphotropic virus type Iis endemic in Japan, parts of central Africa, the Caribbean basin and
South America, Melanesia and Iran (city of Mashhad). The aim of this study was to evaluate serological prevalence
of human T-lymphotropic virus type I/IIinfecon among blood donors, major thalassemic paents and individuals
infected with hepas B and C viruses in the city of Isfahan, Iran.
Materials and Methods: Sera were collected from 140 blood donors (440 samples), 150 major thalassemic paents
,150 and individuals with hepas B and C and were tested for the presence of human T-lymphotropic virus type I/
IIspecific anbody in a 6 months period in 2007using ELISA and Western Blot tests
Results: Blood donors tested were negave for human T-lymphotropic virus type I/IIinfecon, but in major thalassemic
paents including 88 males and 62 females, 5 were posive (3.3%). Stascal analyses did not show any significant
difference between genders. In individuals with hepas one was border line (HCV).
Conclusion: The results indicate a low level of coinfecon of human T-lymphotropic virus with HCV in this part
of the country. However, the observaon of a case with borderline findings, among this group and also posive
cases among thalassemic paents, suggests the presence of the virus in blood donor populaon so this virus could
be present in Isfahan but more invesgaon is needed to evaluate the need for screening tests to detec human
T-lymphotropic virus type I among blood donors in Isfahan.connuing screening and educaon of parents and also
mass media educaon against consuming “Fava bean” and “Naphtalen”.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>HTLV-I/II, Hepas C virus, Hepas B virus, Thalassemia</keyword>
	<start_page>75</start_page>
	<end_page>80</end_page>
	<web_url>http://ijbc.ir/browse.php?a_code=A-10-48-11&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
</author_list>


	</article>
</articleset>
</journal>
